Cargando…
Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability
FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in glioblastoma, lung cancer, bladder cancer, oral cancer, head and neck squamous cell carcinoma, gallbladder cancer, and cervical cancer. Various exon breakpoints of FGFR3-TACC3 have been identified in cancers; these were anal...
Autores principales: | Wang, Clark G., Peiris, Malalage N., Meyer, April N., Nelson, Katelyn N., Donoghue, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924825/ https://www.ncbi.nlm.nih.gov/pubmed/36780330 http://dx.doi.org/10.18632/oncotarget.28359 |
Ejemplares similares
-
Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling
por: Nelson, Katelyn N., et al.
Publicado: (2018) -
Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors
por: Li, Fangda, et al.
Publicado: (2020) -
Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation
por: Peiris, Malalage N., et al.
Publicado: (2020) -
Antiparallel Four-Stranded Coiled Coil Specified by a 3-3-1 Hydrophobic Heptad Repeat
por: Deng, Yiqun, et al.
Publicado: (2006) -
FGFR3-TACC3 is an oncogenic fusion protein in respiratory
epithelium
por: Best, Sarah A., et al.
Publicado: (2018)